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Aortic Surgery for Ascending Aortic
Aneurysms Under 5.0 cm in Diameter
in the Presence of Bicuspid Aortic ValveKlaus Kallenbach, MD, PHD,* Thoralf M. Sundt, MD,y
Thomas H. Marwick, MD, PHD, MPHz
AN E U R Y SM O F TH E A S C END I NG AOR T A MA Y CAU S E A CU T E T Y P E A AO R T I C
D I S S E C T I O N , and the primary aim of a prophylactic operation is avoidance of this life-threatening
complication. Current guidelines recommend prophylactic replacement of the aneurysmal ascending
aorta at a diameter of $5.5 cm. However, several reports have shown that nearly 50% of patients with an
acute type A aortic dissection present with an aortic diameter <5.5 cm. It is controversial how to best
respond to these observations. Because surgical advances have led to a reduction of early surgical
mortality between 1% and 3%, many clinicians believe that surgery is warranted in smaller aortas. Given
the frequency of a bicuspid aortic valve (BAV), such a strategy has health implications for this population.Under 5.0 cm in Diameter
Klaus Kallenbach, MD, PhD*
Current guidelines. At ﬁrst glance, it seems
there is no doubt: the guidelines recommend
prophylactic surgical replacement of the ascending
aorta in non-Marfan patients at an aneurysm
diameter of $5.5 cm to avoid an acute type A
aortic dissection (1). This is a class I quoted rec-
ommendation with general agreement of the
writing committee, but the level of evidence is
weak (grade C), based on expert opinion rather
than randomized clinical trials or meta-analyses.
On closer evaluation, it is apparent that the rec-
ommendation is based only on a 1997 study by
Coady et al. (2), which deﬁnes an inﬂexion in the
risk of dissection at an ascending aortic aneurysm
diameter of 6.0 cm; an illustration of this is even
displayed in the guidelines. Less widely known is
that the resulting recommendation of surgery at
5.5 cm is based on the analysis of a heterogeneous
cohort of only 54 patients with aneurysms of the
ascending aorta or aortic arch, including both
connective tissue disease and degenerative etiol-
ogy. Analysis of the aneurysmal growth rate and
aortic diameter at the time of dissection showedthat the incidence of rupture or dissection was
45.2%at an aortic size of>6.0 cm.However, some
additional information is pertinent. Acute dis-
sections or ruptures occurred in this cohort at
diameters<6.0 cm: in 7.1%of thosewith an aortic
diameter<4.0 cm, 8.5% of those with a diameter
of 4.0 to 4.9 cm, and 12.8%with a diameter of 5.0
to 5.9 cm (2). Thus, rupture or dissection occurred
at an aortic diameter <5.5 cm in 22% of inves-
tigated patients. On the basis of this information,
pursuit of the current recommendations of surgery
at a diameter of$5.5 cmwould lead to nearly one-
fourth of patients with an ascending aneurysm
experiencing an acute type A aortic dissection or
aortic rupture, which is a devastating diseasewith
a poor outcome (3). This is surprising, because the
primary aim of aortic aneurysm surgery is the
avoidance of these complications!
There is further evidence that the recommended
cutoff of 5.5 cm may be of harm for a number of
patients with moderate-sized aneurysms of the
ascending aorta. Neri et al. (4) measured the
internal diameter of the ascending aorta by ana-
lyzing aortic samples from 220 patients who
underwent surgery for an acute type A aortic dis-
section. They found that the median aortic diam-
eter was only 41.3 mm for patients with an acute
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1322type A aortic dissection without con-
nective tissue disease. Thus, only 4.7% of
patients with an acute type A aortic dis-
section had an aneurysm of the ascending
aortausing thedeﬁnitionof a 50% increase
in diameter compared with the expected
normal aortic diameter. In the Interna-
tional Registry of Acute Aortic Dis-
section, 59% of 591 patients presenting
with an acute type A aortic dissection had
an ascending aortic diameter<5.5 cm and
40% had a diameter <5.0 cm (5). Inde-
pendent predictors of the occurrence of an
acute typeA aortic dissection at a diameter
<5.5 cm includedhistory of hypertension,
radiating pain, and increasing age. Aortic
size at presentation was unrelated to
mortality. Transesophageal echocardiog-
raphymeasurements of the aortic annulus,
sinus segment, sinotubular junction, and
ascending aorta in 177 non-Marfan
patients with tricuspid aortic valves who
presented with an acute type A aortic
dissection showed that 62% had a max-
imal aortic diameter of<5.5 cm, 42%had
a maximal aortic diameter <5.0 cm, and
>20% had maximal aortic dimensions
<4.5 cm (6).
Thus, these studies show that acute
type A aortic dissection occurs in many
patients at less than the recommended
diameter of 5.5 cm for surgical inter-
vention, so the current aortic diameter
threshold excludes approximately 50%
of patients with an acute type A aortic
dissection from prophylactic replace-
ment of the ascending aorta. Moreover,
risk factors other than the diameter of
the ascending aorta inﬂuence the
development of an acute type A aortic
dissection and must be identiﬁed.
However, the law of Laplace cannot be
ignored; aneurysmal diameter is deﬁni-
tively a risk factor for acute type A aortic
dissection, and the incidence of dis-
section and rupture increases with
increasing size of the ascending aortic
aneurysm (7). The important question
remains: is a diameter of 5.5 cm the right
indication for prophylactic surgery, or
must we readjust to a smaller diameter?
Outcome of prophylactic replacement of
ascending aortic aneurysm. The pri-
mary aim of replacement of the dilatedascending aorta in asymptomatic pa-
tients is the avoidance of an acute type
A aortic dissection; this is truly a pro-
phylactic indication. In patients with
chest pain, immediate surgery is indi-
cated and may be warranted for sig-
niﬁcant valve disease. Various operative
techniques are available for replacement
of the ascending aorta; supracoronary
tube graft replacement is a straightfor-
ward operation indicated for patients
without aneurysmal involvement of
the aortic root. Additional aortic valve
replacement is possible. In cases with
root dilation, the modiﬁed Bentall
operation, in which a vascular tube graft
incorporating a biological or mechanical
aortic valve prosthesis is used to replace
the root after reinsertion of the coronary
ostia, has been the gold standard for
3 decades. Since the 1990s, valve-
preserving techniques for root replace-
ment have become the operation of
choice when the native aortic valve is
structurally intact.
In cardiac surgical centers experi-
enced in aortic surgery, the results of
these techniques are excellent. Today,
the ascending aorta can be replaced
with very low operative mortality and
morbidity. Garrido-Olivares et al. (8)
reported on combined aortic valve re-
placement and supracoronary ascending
aortic replacement in 89 patients with
an operative mortality rate of 2.3%. In a
series of 597 patients reported from
New York, the early mortality rate in
elective patients undergoing the Bentall
procedure was 1.4% for composite grafts
with mechanical valves and 3.7% with
biological valves (9). A group from
South Korea reported an operative
mortality rate of 2.6% in 195 patients,
including 24 urgent patients with an
acute type A aortic dissection (10). For
the valve-sparing reimplantation tech-
nique, the Hannover group reported a
30-day mortality rate of 1.3% in 230
elective patients (11), and the Leipzig
group reported a 0% mortality rate in
151 patients who underwent the David
operation (12). Similar results have
been achieved with the remodeling
technique, with 1% to 3% early deathsin elective patients (13,14). At the
University Hospital Heidelberg, an
analysis of 548 consecutive patients who
underwent surgery for an ascending
aortic aneurysm over a period of 17
years had an average early mortality rate
of 4.8%. However, during the last 5
years, the average mortality rate was
1.6% in 381 patients (including 0%
mortality in the David group), reﬂecting
technical advances in cardiac surgery
and the effect of a large caseload (15).
Encouraged by these results and in
contrast to the current guidelines, we
recommend surgery for an ascending
aortic aneurysm in patients without
connective tissue disease or a BAV at
5.0 cm and less in selected cases.
The balance between the risk of acute
aortic dissection and operative risk. We
must balance the reduced incidence
of acute type A aortic dissection as a
result of earlier surgery against the
operative risk of prophylactic surgery in
an asymptomatic patient. Because the
occurrence of an acute type A aortic
dissection is potentially life threatening
but elective surgical replacement of the
ascending aorta carries relatively low
operative risk, the balance moves toward
earlier surgery; the harm of an acute type
A aortic dissection is greater than the
risk of surgery. Consequently, patients
should undergo surgery at a diameter of
<5.0 cm because many patients expe-
rience dissection at a smaller diameter,
as explained in the preceding text. The
development of an acute type A aortic
dissection is not only triggered by the
size of the aneurysm; factors such as
connective tissue disease (e.g., Marfan
or Loeys-Dietz syndrome), pregnancy,
BAV, familial history of thoracic aortic
aneurysm and dissection, hypertension,
aortic stiffness (measured noninvasive),
normative data instead of absolute aortic
size (such as the Z-score), sex, and
aortic growth may inﬂuence the timing
of the operation, and several of these
factors are already considered in the
effective guidelines (16). Individual
judgment of any patient is pivotal when
calculating operative risk versus the
likelihood of development of an acute
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1323type A aortic dissection. However, as
long as the size of the aneurysm is
believed to be the most important pre-
dictor for the development of an acute
type A aortic dissection, operation
for aneurysms of the ascending aorta
<5.0 cm in diameter is justiﬁed not only
in high-risk patients for acute type A
aortic dissection. Many centers that
specialize in aortic surgery already
operate on ascending aortic aneurysms
<5.0 cm in diameter, and it is time to
reappraise the guidelines.
No, Not Under 5.0 cm
in the Absence of
Connective Tissue
Disease
Thoralf M. Sundt, MDy
No surgeon should approach the victim
of his operation without a sacred dread
and reluctance
dJohn Hunter (17)
Remarkable technological advances in
recent decades have made high-
resolution imaging widely available.
With their broader application, physi-
cians are increasingly confronted with
management of the asymptomatic, and
often incidentally discovered, anatomic
“abnormality.” Gratifying advances in
surgical care have also reduced the
mortality andmorbidity of many elective
operative interventions, and surgeons
are, in turn, increasingly asked to con-
sider “prophylactic” procedures. Because
the risks associated with both the natural
history of these incidentally discovered
abnormalities and the interventions to
“ﬁx them” lie at the low extreme of the
bell-shaped curve, decision making on
the basis of risk/beneﬁt analysis is in-
creasingly challenging. Nowhere is this
dilemma more apparent than in the
debate over management of moderate
nonsyndromic aortic dilation.
The drivers to early aortic inter-
vention are strong. Aortic dissection is
the most common fatal aortic compli-
cation by a factor of 2 or 3, with
abdominal aneurysms more frequentbut less often lethal. Of those with
dissection involving the ascending aorta
who make it to the hospital, one-fourth
will die before discharge; an unknown
number die before diagnosis (18). On
long-term follow up, 10% to 30% of
patients with involvement of the entire
aorta (DeBakey type I) will require late
operation on the distal segments (19)
and late survival falls far below expec-
ted (20). Perhaps a contributing factor
to the operative risk is the likelihood, at
least in the United States, that the
emergent repair will be conducted by a
surgeon performing fewer than 2
operations for acute dissection each year
(21). Add to this the emotional strain
associated with the risk of a catastrophic
event occurring at an uncertain time,
and it is clear why the trend to rec-
ommend elective surgery for aortic
enlargement in a “center of excellence”
has grown over time.
Are we asking the right questions?
How solid are the data? How rational
are our recommendations?
There is no question that aortic dis-
section is a dreaded disease for all of
the reasons stated in the preceding
text, but this alone is not an argument
for indiscriminant aortic replacement.
Diseases of other organs, such as cancer
of the pancreas, have a dismal prognosis
but are not themselves arguments for
prophylactic extirpation of the suscep-
tible site. This is true regardless of the
skill of the surgeon and how close his
or her rate of operative complica-
tions is believed to approach zero. Of
course, with regard to this estimate of
operative outcomes, surgeons (like all
other humans) are subject to illusory
superiority or “the Lake Wobegon
effect” and the literature is ﬂawed by
publication bias, but that is another
discussion (22). Sufﬁce it to note that,
according to the Society of Thoracic
Surgeons database, the operative risk
associated with replacement of the
proximal aorta under elective circum-
stances is 3.4% (23).
The question at hand is “What is
the risk that any individual, speciﬁcally
the one sitting across from me in myofﬁce, will get the dreaded disease?”
and not merely the risk of death should
the patient develop the condition. To
determine this risk, accurate assessment
of both the numerator and the denom-
inator is needed for the given clinical
parameter (risk factor) of interest.
Unfortunately, in most cases, we have
only a global picture of the condition
with very imprecise information on
speciﬁc subsets of patients at risk,
derived in most instances from study of
those experiencing the complication
(the numerator) rather than from the
total population (the denominator).
Speciﬁcally with regard to aortic dis-
section, we have a growing under-
standing of the spectrum of aortic
diameter before dissection among those
experiencing dissection. What we need
to inform our discussion of prophylactic
surgery with our patient in the ofﬁce,
however, is knowledge of the risk of
dissection among those with a given
aortic diameter. The 2 questions yield
dramatically different results; for exam-
ple, the likelihood of female sex with
breast cancer is approximately 99%, but
the likelihood of breast cancer with
female sex is one-ﬁfth that number.
Fortunately, Bayesian analysis can sug-
gest answers to these questions;
unfortunately, it is not always intuitive.
What of the quality of the data that
we do have at hand? One of the ﬁrst
studies concerning the natural history
of thoracic aortic aneurysmal disease
was performed in the early 1960s by
Dr. John Joyce at the Mayo Clinic. In
that study, which was inspired by sur-
gical progress that made intervention
on the dilated aorta a realistic ther-
apeutic option, he identiﬁed the 6.0-cm
mark as a particularly important risk
factor for signiﬁcant aortic complica-
tions (24). Subsequent studies, partic-
ularly those performed by Dr. John
Elefteriades and his collaborators at
Yale University, have conﬁrmed that,
for the ascending aorta, the incidence of
complications rises dramatically at a
diameter of 6.0 cm (25). It is largely on
the basis of these studies that it is rea-
sonable and prudent to replace the
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1324ascending aorta at 5.5 cm in the interest
of providing a bit of a safety margin.
Although it is comforting that a
number of studies by different inves-
tigators point roughly to the same crit-
ical diameter, it should also be noted
that these studies are subject to entry
bias. Far from a population-based
dataset, surgical databases at any large
academic center located in a dense
population and surrounded by multiple
community providers are likely to be
enriched for those patients who experi-
ence complications. I would argue that
the implication is that the risks will
be overestimated even for dilation to 5.5
or 6.0 cm, but what about the mounting
evidence that dissection can occur at
aortic diameters <5.0 cm? Data on
aortic diameter from 591 patients with
type A dissection were reported from the
International Registry of Acute Dis-
section in 2007 (5). The average
ascending aortic diameter was 5.3 cm,
and 40% of patients had an aortic
diameter <5 cm! Surely this argues for
aggressive intervention at lower and
lower diameters.
There are at least 2 problems with
this line of thinking. Given the afore-
mentioned “numerator/denominator
problem,” we cannot make a statement
about the risk of dissection among
patients with aortic diameters <5.0 cm
without considering the denominator,
which in this case is enormous because
most humans have aortas <5.0 cm in
diameter. The second problem is that
the dataset itself includes only those
patients who made it to the hospital.
An unknown number likely died before
entry into the dataset, and their aortic
diameters are unknowable.
I would argue that it is not a surprise
that aortic size alone is a poor predictor
of the risk of aortic complications.
Aortic dissection represents a mechan-
ical failure of the aortic wall. That
failure can be expected when wall stress
exceeds wall strength. The law of
Laplace certainly predicts higher wall
tension with greater aortic radius, but
there is more to the equation than
radius; intraluminal pressure is equallyimportant (law of Laplace: T ¼ PR).
We have no direct assessment of
material strength in clinical practice
today. The presence of a known con-
nective tissue disorder characterized by
medial degeneration suggests reduced
wall strength, as does the dilation itself
in most instances. Incidentally, in the
special case of the BAV, it could be
argued that moderate aortic dilation is
“normal” and not evidence of medial
degeneration. I am not aware of any
data that support greater susceptibility
to dissection or rupture at any given
diameter compared with patients with a
tricuspid valve.
Where does that leave the concerned
clinician anxious to prevent aortic cat-
astrophe? Surely the ideal solution to
the problem is a patient-speciﬁc as-
sessment of the risk of aortic compli-
cations on the basis of noninvasive
imaging assessments of material prop-
erties of the aortic wall and calculation of
wall stress. A similarly patient-speciﬁc
determination of the risks associated
with prophylactic surgery of this type
can now be calculated for coronary
bypass or aortic valve replacement
on the Society of Thoracic Surgeons
website (http://sts.org/quality-research-
patient-safety/quality/risk-calculator-and-
models). In the meantime, our clinical
decision making is likely to be as much
anecdote driven as evidence based. Both
the physician and the patient will be
subject to the decision-making biases
that form the basis for the entire ﬁeld of
behavioral economics (26). The valence
effect will inﬂuence our thinking in
favor of a greater likelihood of a positive
than negative outcome of the surgical
procedure, while the impact of vividly
framing the risk associated with aortic
enlargement as a “time-bomb in my
chest” will push us toward intervention.
Additionally, the certainty effect will
favor a decision to take deﬁnitive action
to eliminate even a small risk of an
event occurring at an unknown time.
This all adds up to a busy operative
schedule, particularly when considering
that 30% to 50% of the approximately
3 million patients in the United Stateswith a BAV will have some aortic
enlargement, as noted in the preceding
text. Still, it is worth remembering John
Hunter’s admonition and recognizing
that at some point the lines describing
risk and beneﬁt will cross; with an
overly aggressive approach, we will
surely hurt more people than we help.
We don’t know where that point is, but
it exists.Moving Imaging
From Part of the
Problem to Part of
the Solution
Thomas H.Marwick, MD, PhD,MPHz
Current surgical decision making
regarding aortopathy is almost com-
pletely based on the aortic dimension
and surgical plans for the aortic valve.
However, as discussed in the preceding
text, aortic dissections are quite com-
monly reported in vessels that are
smaller than the recommended thresh-
old. Controversy about the appropriate
threshold will be informed by clinical
trials or decision models, but imaging
may be able to inform this better than
simply by provision of aortic dimen-
sions. Indeed, there is nascent evidence
that a number of other observations
may be of value.
In patients with a BAV, leaﬂet mor-
phology may be an important consid-
eration. In a study of 581 patients with
a BAV, a “type 1”morphology (fusion of
the right and left cusps with opening in
an anterior-posterior direction) was
present in 71% of bicuspid valves and
was associated with annulus and sinus
enlargement (27). In a separate study,
this morphology was associated with
aortic regurgitation, whereas fusion of
the right or left cusp with the non-
coronary cusp was associated with aortic
stenosis and enlargement extending into
the aortic arch (28). Indeed, aortic
stenosis has an important association
with aortopathy, with aortic dilation
rates increased similarly in stenotic
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1325bicuspid and tricuspid valves (29). Al-
though the previous teleologic ex-
planation of aortopathy on the basis
of post-stenotic dilation has fallen into
disfavor, there is evidence to show
increased aortic wall stress in the setting
of a right-left fusion of the bicuspid
valve, independent of the severity of
stenosis (30). In this setting, the stenotic
jet is directed anteriorly and to the right,
and this is associated with asymmetric
enlargement of the aortic root, most
commonly on the convexity of the vessel
(31). The resulting inhomogeneity of
circumferential aortic strain has been
associated with the degree of reduced
cusp motion (32). The measurement of
ﬂow direction may be helpful in under-
standing the risk of dissection, given
that most patients with a BAV have
neither symmetrical nor markedly
asymmetrical valves (33). In this issue
of iJACC, Della Corte et al. (34)
describe the importance of aortic mor-
phology to disease progression. In a
study of 133 adult outpatients with a
BAV at baseline, 69% showed fusion on
the right and left aortic cusps, ascending
aortic dilation was present in 57%, and
root dilation was present in 13.5%.
Over an average follow-up of 4 years,
the mean growth rate was 0.3 mm/year
at the sinuses and 0.6 mm/year at
the ascending level. Root phenotype
at presentation, rather than absolute
baseline diameter, was an indepen-
dent predictor of rapid progression
(>0.9 mm/year) for the ascending aorta.
In contrast, the more common ascend-ing phenotype proved a more stable
disease entity, generally with slower
progression. Aortic morphology might
therefore warrant closer surveillance and
earlier treatment of aortopathy, and
indeed a variety of other factors might
also be helpful for decision making.
The nature of the aortic tissue is
another aspect that may be important
in understanding the risk of events.
Measurements of stiffness index and
pulse-wave velocity in patients with a
BAV and hereditary thoracic aneurysms
have shown a relationship between
stiffness and progression, but unfortu-
nately the negative predictive value
of abnormal stiffness and pulse-wave
velocity has been only modest, with a
large overlap between patients with
Marfan syndrome, BAV, and familial
aneurysm (35). Thus, current techni-
ques for measurement of aortic tissue
appear insufﬁciently sensitive to play a
role in surgical decision making. How-
ever, evidence of activation of molecular
pathways by hemodynamic and jet-
related stimuli may control extracellular
matrix regulation and thereby link to
aortic thinning and dilation (36–38).
Therefore, tissue measurements may
not provide substantial incremental
information to that provided by jet
characteristics. Nonetheless, although
aortic thickness does not differ between
patients undergoing aortic surgery with
bicuspid and tricuspid valves, patients
with BAV are reported to have thinner
elastic lamellae and a greater distance
between lamellae (39).The current guidelines for surgery in
aortopathy are heavily dependent on
measurement of aortic dimension.
However, these measurements have a
number of limitations, not the least of
which is how best (or whether at all) to
index the measurement for size. A more
sophisticated risk evaluation approach
should be considered, incorporating the
morphology of the aorta, the severity of
aortic stenosis, the morphology of the
aortic valve, and perhaps also the
characteristics of the aortic wall tissue.
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